Risk factors

Rapid headcount and facility expansion strain management and quality control.

A new U.S. law effective November 12, 2026 could eliminate most BHB hemp-derived THC products.

Velos Acquisition I Corp. adjusted its risk profile around its pending business combination with ReserveOne, warrant dilution, and sponsor loan conversions.

Vuzix highlights cross-border executive travel hurdles, strict environmental recycling rules, and expanding international contract manufacturing partnerships like Quanta Computer.

Weis Markets added financial restatement risks due to an inventory overstatement at a single meat plant, alongside new tariff concerns.

Xenetic Biosciences is pursuing strategic alternatives, including a potential business combination or asset sale. The company faces ongoing challenges in meeting Nasdaq listing requirements, underscored by recent meeting adjournments due to a lack of quorum.

ZEC price volatility, network disruptions and forks dominate the risk disclosures.

Zumiez updated its competitive risk disclosure, though the underlying text on rivals, ecommerce shipping, and pricing pressure remains identical.

Acme United Corp added operational risks regarding artificial intelligence and new 2025 tariffs on Canada, Mexico, and the EU.

Activate Energy Acquisition Corp. raised $230 million in its IPO on December 5, 2025. The company operates as a blank check entity seeking an energy business combination. Management faces going concern uncertainties due to limited operating cash and capital resources.

Customer concentration details emerged, showing two specific customers generated 24% and 15% of revenue in 2025. Tariff disclosures shifted from specific February 2025 presidential announcements to broader ongoing trade disputes and Chinese import tariffs.

BillionToOne faces key risks regarding third-party payor reimbursement, heavy dependence on Union City laboratory facilities, and complex molecular diagnostic competition.